Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
Lower tax rates overseas “drove a lot of the innovative companies to make drugs in low-tax islands like Ireland and Singapore and Switzerland,” said David Ricks, chief executive of Eli Lilly.
Simplified Text
David Ricks said lower tax rates overseas drove innovative companies to make drugs in low-tax islands like Ireland Singapore Switzerland.
Confidence Score
0.900
Claim Maker
David Ricks
Context Type
News Article
Context Details
{
    "topic": "Tax rates",
    "person": "David Ricks",
    "industry": "Pharmaceutical",
    "location": "Ireland, Singapore, Switzerland",
    "organization": "Eli Lilly"
}
UUID
9fdb5dbf-9698-4276-bf8d-2195231f4157
Vector Index
✗ No vector
Created
September 12, 2025 at 2:46 AM (2 days ago)
Last Updated
September 12, 2025 at 2:46 AM (2 days ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://www.nytimes.com/2025/08/14/health/pharma-tariffs-ireland-taxes.html?campaign_id=9&emc=edit_nn_20250815&instance_id=160603&nl=the-morning&regi_id=122976029&segment_id=203954&user_id=b25c5730c89e0c73f75709d8f1254337
https://www.nytimes.com/2025/08/14/health/pharma-tariffs-ireland-taxes.html?campaign_id=9&emc=edit_nn_20250815&instance_id=160603&nl=the-morning&regi_id=122976029&segment_id=203954&user_id=b25c5730c89e0c73f75709d8f1254337

US drugmakers using Ireland for tax advantages face billions in tariffs from planned 15% levy on European medicines. Companies may shift production to the US, incurring increased costs.

Pharmaceutical Industry
International Trade
Taxation
Ireland
United States
Tariffs
Corporate Tax Avoidance

Similar Claims (0)

Other claims identified as semantically similar to this one.

No similar claims found

This claim appears to be unique in the system.

Claim Management System - MVP